India's Pharmaceutical Exports

Country Profile

France

France is a major destination for Indian pharmaceutical exports — $779M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 80% of shipments, with vaccines contributing $2.78M. The compound annual growth rate since FY2015 stands at 14.0%.

🇫🇷 #8 Destination · $779M · 4.2× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$779M
Exports FY2025–26 DGCIS
4.2×
Growth FY2015→2026
2.5%
Share of India Total
#8
Rank Among 178 Markets
14.0%
CAGR FY2015→2026
France is a major destination for Indian pharmaceutical exports — $779M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 80% of shipments, with vaccines contributing $2.78M. The compound annual growth rate since FY2015 stands at 14.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $623M (79.9%) Medicine Ingredients $116M (14.9%) Traditional & Herbal $24.5M (3.1%) Surgical & Hospital Supplies $13.2M (1.7%) Vaccines $2.78M (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to France in the RBI overseas direct investment dataset (2011–2026).